These CD127–CD103+CD39+CD45RO+ ILCs constituted up to 16% of the immune cell infiltrate in pancreatic tumors (figure 3B), and were present at a higher relative frequency than in non-malignant tissue (p<0.05 by Mann-Whitney test; figure 3B). The gene discussed is ENTPD1; the disease is pancreatic neoplasm.